Table 4.

Mean ± Standard Error (Likert scale from -5 to +5) sort in descending order to the question “How much does HC/HT increase or reduce the risk of developing these cancers?” for the whole study group and for the whole study group and for premenopausal vs. postmenopausal women, separately.

How much does HC/HT increase or reduce the risk of developing these cancers?
	Total group (n = 370)	Premenopausal women (n = 198)	Postmenopausal Women (n = 172)	p
Breast cancer	0.9 ± 0.1	0.7 ± 0.2	1.1 ± 0.2	.21
Uterine cervix cancer	0.4 ± 0.1	0.2 ± 0.1	0.5 ± 0.2	.33
Uterine body cancer	0.2 ± 0.1	0.0 ± 0.2	0.5 ± 0.2	.04
Ovarian cancer	0.0 ± 0.1	−0.6 ± 0.1	0.6 ± 0.2	<.0001
Colorectal cancer	−0.2 ± 0.1	−0.4 ± 0.1	−0.1 ± 0.2	.03

Bold characters represent statistically significant results (p < .05).